Veneno Technologies Co. Ltd. has been selected for “The Masterclass Program by BioLabs – cohort2,” an acceleration program for life science startups.
This program is designed to support startups in the life sciences sector in strengthening their business strategies with a view toward global expansion. Through expert mentoring, pitch coaching, and networking opportunities with corporations and investors, the program supports startups in accelerating their growth in the global market.
Veneno Technologies is developing and providing “Veneno Suite™,” its proprietary Disulfide-Rich Peptide（DRP）discovery platform specialized in DRP-based drug discovery. Through participation in this program, Veneno Technologies aims to deepen its knowledge in business development, fundraising, and regulatory strategy for global expansion, while creating opportunities for collaboration with pharmaceutical companies, biotech companies, and investors.
Veneno Technologies will continue to explore the potential of DRPs and work toward creating new values in drug discovery.
Related link:
LINK-J article: “Selected startups announced! The Masterclass Program by BioLabs – cohort2”
